Mark S. Gold

Q: What Schools Are Affiliated With Mark S. Gold

Mark S. Gold is affiliated with the following schools: Washington University in St. Louis, Yale University, University of Florida, University of Miami, University of Florida College of Medicine

Mark S. Gold's AcademicInfluence.com Rankings

Mark S. Gold

Psychology

#1797

World Rank

#2140

Historical Rank

#993

USA Rank

psychology Degrees

Mark S. Gold

Philosophy

#3789

World Rank

#6065

Historical Rank

#1172

USA Rank

Logic

#1421

World Rank

#2169

Historical Rank

#428

USA Rank

philosophy Degrees

Download Badge

Psychology
Philosophy

Mark S. Gold's Degrees

PhD Psychology University of Miami

Why Is Mark S. Gold Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Mark S. Gold is an American physician, professor, author, and researcher on the effects of opioids, cocaine, tobacco, and other drugs as well as food on the brain and behavior. He is married to Janice Finn Gold.

(See a Problem?)

Mark S. Gold's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Problematic internet use: Proposed classification and diagnostic criteria (2003) (714)
CLONIDINE BLOCKS ACUTE OPIATE-WITHDRAWAL SYMPTOMS (1978) (663)
New concepts in cocaine addiction: The dopamine depletion hypothesis (1985) (582)
Methamphetamine Causes Microglial Activation in the Brains of Human Abusers (2008) (334)
Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment. (1980) (304)
Hormonal and neural mechanisms of food reward, eating behaviour and obesity (2014) (224)
Hypothyroidism and depression. Evidence from complete thyroid function evaluation. (1981) (216)
Comorbid cigarette and alcohol addiction: epidemiology and treatment. (1998) (211)
"Liking" and "wanting" linked to Reward Deficiency Syndrome (RDS): hypothesizing differential responsivity in brain reward circuitry. (2012) (205)
CLONIDINE IN OPIATE WITHDRAWAL (1978) (195)
Setting the standard for recovery: Physicians' Health Programs. (2009) (179)
Dysfunctional connectivity patterns in chronic heroin users: An fMRI study (2009) (178)
Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal. (1979) (168)
Overeating, Binge Eating, and Eating Disorders as Addictions (2003) (164)
Genetic Addiction Risk Score (GARS): Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS) (2014) (161)
Dopamine and glucose, obesity, and reward deficiency syndrome (2014) (160)
Neurobiology of food addiction (2010) (159)
Human Traumatic Brain Injury Induces Autoantibody Response against Glial Fibrillary Acidic Protein and Its Breakdown Products (2014) (154)
The Salted Food Addiction Hypothesis may explain overeating and the obesity epidemic. (2009) (151)
Tossing the baby out with the bathwater after a brief rinse? The potential downside of dismissing food addiction based on limited data (2012) (147)
Body Mass Index and Alcohol Use (2004) (143)
Further developments in the neurobiology of food and addiction: update on the state of the science. (2012) (140)
Dissociation of "conscious desire" (craving) from and relapse in alcohol and cocaine dependence. (1994) (134)
rsfMRI effects of KB220Z™ on neural pathways in reward circuitry of abstinent genotyped heroin addicts (2015) (129)
Obesity: Pathophysiology and Intervention (2014) (129)
A REVIEW OF KETAMINE ABUSE AND DIVERSION (2016) (128)
Prescription opioid abuse and dependence among physicians: hypotheses and treatment. (2008) (128)
Dexmedetomidine for Awake Carotid Endarterectomy: Efficacy, Hemodynamic Profile, and Side Effects (2004) (127)
The American Psychiatric Publishing Textbook of Substance Abuse Treatment (2009) (115)
CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat (2013) (114)
Methamphetamine- and Trauma-Induced Brain Injuries: Comparative Cellular and Molecular Neurobiological Substrates (2009) (109)
The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence (2005) (108)
Single-dose bromocriptine reverses cocaine craving (1987) (107)
Food and addiction - sugars, fats and hedonic overeating. (2011) (106)
From Coca Leaves to Crack: The Effects of Dose and Routes of Administration in Abuse Liability (1988) (105)
Chronic Cocaine Abuse: Evidence for Adverse Effects on Health and Functioning (1984) (103)
Eating disorders and cocaine abuse: a survey of 259 cocaine abusers. (1987) (103)
Molecular role of dopamine in anhedonia linked to reward deficiency syndrome (RDS) and anti- reward systems. (2018) (100)
Antagonism of CRF Receptors Prevents the Deficit in Brain Reward Function Associated with Precipitated Nicotine Withdrawal in Rats (2007) (100)
BROMOCRIPTINE AS TREATMENT OF COCAINE ABUSE (1985) (98)
Dopamine in the Brain: Hypothesizing Surfeit or Deficit Links to Reward and Addiction (2015) (96)
PATHOS: A Brief Screening Application for Assessing Sexual Addiction (2012) (96)
“Symptomless” autoimmune thyroiditis in depression (1982) (95)
Enhanced functional connectivity and volume between cognitive and reward centers of naïve rodent brain produced by pro-dopaminergic agent KB220Z (2017) (95)
Reward circuitry dopaminergic activation regulates food and drug craving behavior. (2011) (94)
Predicting subsequent relapse by drug‐related cue‐induced brain activation in heroin addiction: an event‐related functional magnetic resonance imaging study (2015) (94)
Gray matter deficits and resting-state abnormalities in abstinent heroin-dependent individuals (2010) (91)
Cocaine abuse: neurochemistry, phenomenology, and treatment. (1985) (90)
Dopamine homeostasis: brain functional connectivity in reward deficiency syndrome. (2017) (88)
A comparison of regional and general anesthesia in patients undergoing carotid endarterectomy. (1996) (87)
Sex, Drugs, and Rock ‘N’ Roll: Hypothesizing Common Mesolimbic Activation as a Function of Reward Gene Polymorphisms (2012) (86)
Naltrexone in addicted business executives and physicians. (1984) (84)
Fentanyl Abuse and Dependence (2006) (84)
Sexual dysfunction in abusers of cocaine and alcohol. (1988) (84)
Persistence of urinary marijuana levels after supervised abstinence. (1982) (83)
The TRH test in the diagnosis of major and minor depression (1981) (83)
Systematic Evaluation of “Compliance” to Prescribed Treatment Medications and “Abstinence” from Psychoactive Drug Abuse in Chemical Dependence Programs: Data from the Comprehensive Analysis of Reported Drugs (2014) (82)
Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine. (1993) (82)
Food Addiction and Obesity: Evidence from Bench to Bedside (2010) (81)
Food and addiction: a comprehensive handbook. (2012) (81)
The human sexual response and alcohol and drugs. (1988) (81)
Body Mass Index and Marijuana Use (2005) (80)
The use of opiate antagonists in treating bulimia: A study of low-dose versus high-dose naltrexone (1988) (80)
Pharmacological approaches to cocaine addiction. (1985) (80)
Overlaps in the nosology of substance abuse and overeating: the translational implications of "food addiction". (2011) (80)
Naltrexone, opiate addiction, and endorphins (1982) (80)
TRH-induced TSH response in unipolar, bipolar, and secondary depressions: Possible utility in clinical assessment and differential diagnosis (1980) (79)
Alcohol and drug dependence among the elderly: epidemiology, diagnosis, and treatment. (1991) (78)
Violent behaviors associated with cocaine use: possible pharmacological mechanisms. (1991) (77)
Evaluating depression in alcoholics (1986) (77)
Marijuana and Tobacco (2003) (77)
Endorphin-locus coeruleus connection mediates opiate action and withdrawal. (1979) (76)
Relationship of Thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression (1981) (75)
Caffeine content of decaffeinated coffee. (2006) (74)
Altered small-world brain functional networks and duration of heroin use in male abstinent heroin-dependent individuals (2010) (73)
Attention-Deficit/Hyperactivity Disorder: Is it time to Reappraise the Role of Sugar Consumption? (2011) (73)
Neurogenetics of Dopaminergic Receptor Supersensitivity in Activation of Brain Reward Circuitry and Relapse: Proposing “Deprivation-Amplification Relapse Therapy” (DART) (2009) (73)
Tobacco smoke exposure induces nicotine dependence in rats (2009) (72)
Fentanyl and Propofol Exposure in the Operating Room: Sensitization Hypotheses and Further Data (2008) (72)
Sexual dysfunction secondary to cocaine abuse in two patients. (1986) (72)
Common Neurogenetic Diagnosis and Meso-Limbic Manipulation of Hypodopaminergic Function in Reward Deficiency Syndrome (RDS): Changing the Recovery Landscape (2016) (70)
Clinically Combating Reward Deficiency Syndrome (RDS) with Dopamine Agonist Therapy as a Paradigm Shift: Dopamine for Dinner? (2015) (70)
Lifetime Psychiatric and Substance Use Disorders Among Impaired Physicians in a Physicians Health Program: Comparison to a General Treatment Population Psychopathology of Impaired Physicians (2013) (69)
The Molecular Neurobiology of Twelve Steps Program & Fellowship: Connecting the Dots for Recovery (2015) (69)
The relationship of addiction, tolerance, and dependence to alcohol and drugs: a neurochemical approach. (1987) (69)
Drug Abuse and Bipolar Disorders (1986) (69)
Plasma cortisol and beta-endorphin immunoreactivity in nonmajor and major depression. (1984) (68)
A Systematic, Intensive Statistical Investigation of Data from the Comprehensive Analysis of Reported Drugs (CARD) for Compliance and Illicit Opioid Abstinence in Substance Addiction Treatment with Buprenorphine/naloxone (2018) (67)
USE OF PSYCHOTROPIC DRUGS IN TREATMENT OF METHADONE MAINTAINED NARCOTIC ADDICTS * (1978) (67)
Low Dopamine Function in Attention Deficit/Hyperactivity Disorder: Should Genotyping Signify Early Diagnosis in Children? (2014) (66)
Second-hand exposure to aerosolized intravenous anesthetics propofol and fentanyl may cause sensitization and subsequent opiate addiction among anesthesiologists and surgeons. (2006) (65)
Cocaine dependence: alcohol and other drug dependence and withdrawal characteristics. (1993) (64)
Naltrexone in addicted physicians and business executives. (1984) (64)
The Psychoactive Designer Drug and Bath Salt Constituent MDPV Causes Widespread Disruption of Brain Functional Connectivity (2016) (63)
Concurrent calpain and caspase-3 mediated proteolysis of alpha II-spectrin and tau in rat brain after methamphetamine exposure: a similar profile to traumatic brain injury. (2005) (63)
Psychopharmacology of Cocaine (1988) (62)
Neurobiology of tobacco smoking and other addictive disorders. (1999) (62)
Distinct resting-state brain activities in heroin-dependent individuals (2011) (62)
Neuro-psychopharmacogenetics and Neurological Antecedents of Posttraumatic Stress Disorder: Unlocking the Mysteries of Resilience and Vulnerability (2010) (62)
Occupational exposure and addictions for physicians: case studies and theoretical implications. (2004) (61)
Role of the laboratory in the evaluation of suspected drug abuse. (1986) (61)
Bromocriptine Treatment for Cocaine Abuse: The Dopamine Depletion Hypothesis (1986) (60)
ANTIMANIC, ANTIDEPRESSANT, AND ANTIPANIC EFFECTS OF OPIATES: CLINICAL, NEUROANATOMICAL, AND BIOCHEMICAL EVIDENCE (1982) (60)
Neurobiological mechanisms in addictive and psychiatric disorders. (2004) (59)
Cocaine : a clinician's handbook (1987) (57)
Conceptualizing Addiction From an Osteopathic Perspective: Dopamine Homeostasis (2018) (57)
Neuro-Genetics of Reward Deficiency Syndrome (RDS) as the Root Cause of "Addiction Transfer": A New Phenomenon Common after Bariatric Surgery. (2011) (56)
Clonidine in acute opiate withdrawal. (1980) (56)
Specificity of the DST and the TRH test for major depression in alcoholics. (1984) (56)
NALTREXONE REVERSES BULIMIC SYMPTOMS (1986) (55)
A rationale for opiate withdrawal symptomatology. (1979) (55)
Cocaine abuse and adult attention deficit disorder. (1987) (55)
Performance Enhancing, Non-Prescription Use of Ritalin (2007) (55)
Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats (2016) (55)
Rapid opiate detoxification: clinical evidence of antidepressant and antipanic effects of opiates. (1979) (53)
Diagnosis of depression in the 1980s. (1981) (53)
Neurogenetics and Epigenetics in Impulsive Behaviour: Impact on Reward Circuitry. (2012) (53)
Using the protirelin test to distinguish mania from schizophrenia. (1982) (52)
Suicide risk associated with drug and alcohol dependence. (1991) (52)
Deficient prolactin response to morphine in depressed patients. (1980) (51)
Calpain- and caspase-mediated alphaII-spectrin and tau proteolysis in rat cerebrocortical neuronal cultures after ecstasy or methamphetamine exposure. (2007) (51)
Calpain and caspase proteolytic markers co-localize with rat cortical neurons after exposure to methamphetamine and MDMA (2007) (51)
Adolescent Drug Addiction Treatment and Weight Gain (2004) (51)
ANOREXIC EFFECTS OF NALTREXONE IN MAN (1982) (50)
Dopamine Genetics and Function in Food and Substance Abuse. (2013) (50)
Neurogenetic and epigenetic correlates of adolescent predisposition to and risk for addictive behaviors as a function of prefrontal cortex dysregulation. (2015) (50)
Management of withdrawal syndromes and relapse prevention in drug and alcohol dependence. (1998) (49)
Chronic Methamphetamine Effects on Brain Structure and Function in Rats (2016) (49)
The physiology of cocaine craving and 'crashing'. (1987) (48)
The dexamethasone suppression test in depressed adolescents. (1982) (48)
ANTIPSYCHOTIC EFFECT OF OPIATE AGONISTS (1977) (48)
Do dopaminergic gene polymorphisms affect mesolimbic reward activation of music listening response? Therapeutic impact on Reward Deficiency Syndrome (RDS). (2010) (48)
Medication-Assisted Treatment for Opioid-Use Disorder. (2019) (48)
Efficacy of clonidine in opiate withdrawal: a study of thirty patients. (1980) (48)
Food addiction and neuroimaging. (2011) (48)
Adolescent drug abuse. Diagnosis, treatment, and prevention. (1986) (46)
Interaction of Satiety and Reward Response to Food Stimulation (2004) (46)
Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm surgery. A prospective, randomized study. (1990) (46)
Initiation and Progression of Alcohol, Marijuana, and Cocaine Use Among Adolescent Abusers (1995) (45)
Substance Use Disorders and Behavioral Addictions During the COVID-19 Pandemic and COVID-19-Related Restrictions (2021) (44)
Substance Use Disorders and Telehealth in the COVID-19 Pandemic Era (2020) (44)
Grades of thyroid failure in 100 depressed and anergic psychiatric inpatients. (1981) (44)
The thyrotropin-releasing hormone test in the diagnosis of unipolar depression (1981) (44)
The mirage of impairing drug concentration thresholds: a rationale for zero tolerance per se driving under the influence of drugs laws. (2012) (43)
The neurobiological drive for overeating implicated in Prader–Willi syndrome (2015) (43)
PRECLINICAL STUDY: Changes in leptin, ghrelin, growth hormone and neuropeptide‐Y after an acute model of MDMA and methamphetamine exposure in rats (2008) (43)
DISTINGUISHING UNIPOLAR AND BIPOLAR DEPRESSION BY THYROTROPIN RELEASE TEST (1979) (43)
The use of clonidine in detoxification from opiates. (1980) (43)
Family history and diagnosis of alcohol dependence in cocaine dependence (1989) (42)
Addiction to Food and Brain Reward Systems (2005) (42)
Neuro-chemical activation of brain reward meso-limbic circuitry is associated with relapse prevention and drug hunger: a hypothesis. (2011) (42)
Epigenetic Modulation of Mood Disorders. (2013) (41)
Tobacco smoking and nicotine dependence: biological basis for pharmacotherapy from nicotine to treatments that prevent relapse. (1998) (41)
Severe Deficit in Brain Reward Function Associated with Fentanyl Withdrawal in Rats (2006) (41)
The diagnosis of alcohol and cannabis dependence in cocaine dependents and alcohol dependence in their families. (1989) (40)
The Psychopharmacology of Cocaine (1984) (40)
The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed borderline patients (1983) (40)
Treatment of Antidepressant-Resistant Bulimia with Naltrexone (1987) (39)
Altered functional brain networks in Prader–Willi syndrome (2013) (39)
Psychoproteomic analysis of rat cortex following acute methamphetamine exposure. (2008) (39)
Drug withdrawal and hyperphagia: lessons from tobacco and other drugs. (2011) (39)
Crossroads of pain and addiction. (2010) (39)
THE NEUROBIOLOGICAL IMPLICATIONS OF CLONIDINE HCl (1981) (38)
Successful use of naltrexone in addicted physicians and business executives. (1984) (38)
Methadone- and Heroin-Related Deaths in Florida (2008) (38)
Effects of sustained gamma-hydroxybutyrate treatments on spontaneous and evoked firing activity of locus coeruleus norepinephrine neurons (2004) (38)
Preclinical evidence for the addiction potential of highly palatable foods: Current developments related to maternal influence (2017) (37)
Putative Dopamine Agonist (KB220Z) Attenuates Lucid Nightmares in PTSD Patients: Role of Enhanced Brain Reward Functional Connectivity and Homeostasis Redeeming Joy (2015) (37)
NIDA-Drug Addiction Treatment Outcome Study (DATOS) Relapse as a Function of Spirituality/Religiosity (2015) (36)
Clonidine decreases opiate withdrawal-related anxiety: possible opiate noradrenergic interaction in anxiety and panic. (1980) (36)
The diagnosis of marijuana (cannabis) dependence. (1989) (36)
Opiate detoxification with lofexidine. (1981) (36)
The Effect of Lumbar Epidural and General Anesthesia on Plasma Catecholamines and Hemodynamics During Abdominal Aortic Aneurysm Repair (1994) (36)
Brief intervention for medical inpatients with unhealthy alcohol use. (2007) (35)
Medical and psychiatric complications of cocaine abuse with possible points of pharmacological treatment. (1985) (35)
Methadone and morphine in depression [proceedings]. (1981) (35)
The Food and Drug Addiction Epidemic: Targeting Dopamine Homeostasis. (2017) (35)
From bedside to bench and back again: A 30-year saga (2011) (35)
The Neurobiology of Cocaine (1993) (35)
METHADONE INDUCED HYPOADRENALISM (1982) (35)
DEXAMETHASONE SUPPRESSION TESTS IN DEPRESSION AND RESPONSE TO TREATMENT (1980) (34)
Psychiatric research: psychoproteomics, degradomics and systems biology (2008) (33)
Naltrexone treatment of bulimia: clinical and theoretical findings linking eating disorders and substance abuse. (1988) (33)
Naltrexone Augments the Effects of Nicotine Replacement Therapy in Female Smokers (2005) (33)
COCAINE ABUSE AND EATING DISORDERS (1986) (33)
Addictiveness of central stimulants. (1990) (33)
Qualitative versus quantitative methods in psychiatric research. (2012) (33)
Does subclinical hypothyroidism predispose to tricyclic-induced rapid mood cycles? (1982) (32)
Neurogenetics and gene therapy for reward deficiency syndrome: are we going to the Promised Land? (2015) (32)
Alcohol consumption associated with collegiate American football pre-game festivities. (2011) (31)
Food consumption and weight gain after cessation of chronic amphetamine administration (2014) (31)
Fetal effects of maternal alcohol use. (1983) (30)
Identification of Proteins Sensitive to Thermal Stress in Human Neuroblastoma and Glioma Cell Lines (2012) (30)
CLONIDINE AND OPIATE WITHDRAWAL (1980) (30)
Plasma haloperidol levels and clinical response in acute schizophrenia. (1982) (30)
Variety and hyperpalatability: are they promoting addictive overeating? (2011) (30)
Using the Neuroadaptagen KB200z™ to Ameliorate Terrifying, Lucid Nightmares in RDS Patients: the Role of Enhanced, Brain-Reward, Functional Connectivity and Dopaminergic Homeostasis (2015) (29)
Effects of baclofen and naltrexone, alone and in combination, on the consumption of palatable food in male rats. (2014) (29)
Preliminary findings of patterns of substance abuse in eating disorder patients. (1992) (29)
TRH test in depression. (1980) (28)
Thyroid failure and protirelin (thyrotropin-releasing hormone) test abnormalities in depressed outpatients. (1983) (28)
Cocaine abuse, attention deficit disorder, and bipolar disorder. (1987) (28)
Psychiatric Complications of Antihypertensive Medications (1981) (28)
Clonidine: inpatient studies from 1978 to 1981. (1982) (28)
Beyond Supply: How We Must Tackle the Opioid Epidemic. (2018) (28)
Opiate addiction and depression--cause or effect? (1983) (27)
Dopamine D2 gene expression interacts with environmental enrichment to impact lifespan and behavior (2016) (27)
Differentiating mania from schizophrenia by the TRH test. (1980) (27)
Diagnosis of Substance Abuse in an Adolescent Psychiatric Population (1987) (27)
The relationship between obesity and drug use. (2007) (27)
The thyroid-stimulating hormone response to thyrotropin-releasing hormone in mania and bipolar depression (1980) (27)
A 12-step treatment approach for marijuana (Cannabis) dependence. (1989) (26)
Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)? (2014) (26)
Weight Gain After Adolescent Drug Addiction Treatment and Supervised Abstinence (2003) (26)
Evidence for an endorphin dysfunction in methadone addicts: lack of ACTH response to naloxone. (1981) (26)
INTRANASAL COCAINE ADDICTION (1983) (26)
Comparing the effects of food restriction and overeating on brain reward systems (2013) (26)
Can Drug Design Inhibit Abuse? (2005) (25)
Molecular neurological correlates of endorphinergic/dopaminergic mechanisms in reward circuitry linked to endorphinergic deficiency syndrome (EDS) (2020) (25)
Hypothesizing that designer drugs containing cathinones ("bath salts") have profound neuro-inflammatory effects and dangerous neurotoxic response following human consumption. (2013) (25)
Clonidine in mania (1983) (25)
Thyroid-stimulating hormone response to thyrotropin-releasing hormone in unipolar depression before and after clinical improvement (1982) (25)
Dexmedetomidine Does Not Increase the Incidence of Intracarotid Shunting in Patients Undergoing Awake Carotid Endarterectomy (2006) (25)
Tolerance and Dependence (1991) (24)
Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms (2021) (24)
The next generation of obesity treatments: beyond suppressing appetite (2013) (24)
Animal Models Lead the Way to Further Understanding Food Addiction as Well as Providing Evidence that Drugs Used Successfully in Addictions Can Be Successful in Treating Overeating (2013) (24)
Manual of therapeutics for addictions. (1997) (24)
Granger causality reveals a dominant role of memory circuit in chronic opioid dependence (2017) (24)
A Shared Molecular and Genetic Basis for Food and Drug Addiction: Overcoming Hypodopaminergic Trait/State by Incorporating Dopamine Agonistic Therapy in Psychiatry. (2015) (23)
Substance use disorder a bio-directional subset of reward deficiency syndrome. (2017) (23)
Prevalence of drug and alcohol use in urban Afghanistan: epidemiological data from the Afghanistan National Urban Drug Use Study (ANUDUS). (2014) (23)
Neurological correlates of brain reward circuitry linked to opioid use disorder (OUD): Do homo sapiens acquire or have a reward deficiency syndrome? (2020) (22)
Pharmacologic approaches to the treatment of cocaine dependence. (1990) (22)
Correction: Identification of Proteins Sensitive to Thermal Stress in Human Neuroblastoma and Glioma Cell Lines (2012) (22)
A POSSIBLE OPIOID RECEPTOR DYSFUNCTION IN SOME DEPRESSIVE DISORDERS (1982) (22)
Cocaine: general characteristics, abuse, and addiction. (1989) (22)
Effects of Environmental Tobacco Smoke on Adult Rat Brain Biochemistry (2010) (22)
Tobacco and Psychiatric Dual Disorders (2007) (22)
Recent trends in cocaine abuse: a view from the National Hotline, "800-COCAINE". (1986) (22)
The diagnosis of alcohol and cannabis dependence in cocaine dependence. (1990) (22)
Hypothesized neurochemical models for psychiatric syndromes in alcohol and drug dependence. (1993) (22)
Biomarkers in psychiatry: how close are we? (2013) (21)
Psychiatric applications of thyroid tests. (1986) (21)
Treatment resistant opioid use disorder (TROUD): Definition, rationale, and recommendations (2020) (21)
Seeking Drugs/Alcohol and Avoiding Withdrawal: The Neuroanatomy of Drive States and Withdrawal (1992) (21)
Weight Gain During Substance Abuse Treatment (2007) (21)
Physician suicide and drug abuse. (2005) (21)
Risks and Benefits of Cannabis and Cannabinoids in Psychiatry. (2021) (21)
Food Addiction and Cues in Prader-Willi Syndrome (2009) (20)
Withdrawal and Reward: Implications for Detoxification and Relapse Prevention (1995) (20)
Pharmacological adjuncts in the treatment of opioid and cocaine addicts. (1988) (20)
Abuse, addiction, tolerance, and dependence to benzodiazepines in medical and nonmedical populations. (1991) (20)
Criminal activity and crack addiction. (1995) (20)
Epidemiology of benzodiazepine use and dependence. (1995) (20)
Food Addiction and Psychosocial Adversity: Biological Embedding, Contextual Factors, and Public Health Implications (2020) (19)
Laboratory Testing in the Diagnosis of Marijuana Intoxication and Withdrawal (1986) (19)
Are Physicians and Medical Students Prepared to Educate Patients About Alcohol Consumption? (2004) (19)
A Study of Violent Behaviors Associated with Cocaine Use: Theoretical and Pharmacological Implications (1990) (19)
Benzodiazepines: tolerance, dependence, abuse, and addiction. (1990) (19)
'Crack'. Early report on a new drug epidemic. (1986) (19)
Psychiatric Diagnosis in Alcohol and Drug Dependence (1991) (19)
Hypothesizing dopaminergic genetic antecedents in schizophrenia and substance seeking behavior. (2014) (19)
Hypothyroidism--or is it depression? (1983) (18)
Amphetamines: pharmacology, abuse and addiction. (1989) (18)
Introduction benzodiazepines: A major problem (1991) (18)
Pharmacotherapies for Overeating and Obesity. (2013) (18)
Methods in drug abuse models: comparison of different models of methamphetamine paradigms. (2012) (18)
Endorphins, lithium, and naloxone: their relationship to pathological and drug-induced manic-euphoric states. (1978) (18)
Effects of fentanyl dose and exposure duration on the affective and somatic signs of fentanyl withdrawal in rats (2008) (18)
The effects of buprenorphine on fentanyl withdrawal in rats (2007) (18)
The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer’s in Aging African-Americans (2018) (18)
Neurotransmitter and neuroendocrine abnormalities associated with cocaine use. (1985) (18)
Dependence Syndrome: A Critical Analysis of Essential Features (1991) (17)
Suggestions for changes in DSM-III-R criteria for substance use disorders. (1989) (17)
The diagnosis of alcohol and cannabis dependence (addiction) in cocaine dependence (addiction). (1990) (17)
Platelet serotonin transporter in cocaine patients. (1984) (17)
Speed of onset of action of the newer antidepressants. (1984) (17)
Cocaine update: from bench to bedside. (1985) (17)
Coupling Neurogenetics (GARS™) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome (RDS): Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms (2015) (17)
Human Functional Magnetic Resonance Imaging of Eating and Satiety in Eating Disorders and Obesity (2003) (17)
Survey of 500 callers to a national cocaine helpline. (1984) (17)
Dual Diagnosis in Substance Abuse (1991) (17)
A hypothesis for a common neurochemical basis for alcohol and drug disorders. (1993) (17)
Decreased serum prolactin in opiate withdrawal and dopaminergic hyperactivity. (1979) (17)
Should the United States Government Repeal Restrictions on Buprenorphine/Naloxone Treatment? (2016) (16)
Reward Deficiency Syndrome: Attentional/Arousal Subtypes, Limitations of Current Diagnostic Nosology, and Future Research (2015) (16)
The Disease and Adaptive Models of Addiction: A Re-Evaluation (1990) (16)
A neurochemical basis for alcohol and other drug addiction. (1993) (16)
Alcohol dependence and its medical consequences. (1988) (16)
Dexamethasone suppression test testing of depressed alcoholics. (1986) (16)
Identification of tyrosine nitration in UCH‐L1 and GAPDH (2011) (16)
Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics (2015) (16)
ANTI-ENDORPHIN EFFECTS OF METHADONE (1980) (16)
The dexamethasone suppression test for major depression among opiate addicts. (1984) (16)
Psychiatric Presentations of Marijuana Abuse (1986) (15)
Molecular Genetic Testing in Reward Deficiency Syndrome (RDS): Facts and Fiction (2015) (15)
Further evidence of hypothalamic-pituitary dysfunction in anorexia nervosa. (1980) (15)
New insights and treatments: opiate withdrawal and cocaine addiction. (1984) (15)
High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial (2021) (15)
Psychostimulant use disorder emphasizing methamphetamine and the opioid -dopamine connection: Digging out of a hypodopaminergic ditch (2020) (15)
Putative COVID- 19 Induction of Reward Deficiency Syndrome (RDS) and Associated Behavioral Addictions with Potential Concomitant Dopamine Depletion: Is COVID-19 Social Distancing a Double Edged Sword? (2020) (15)
Is Speeding a Form of Gambling in Adolescents? (2006) (15)
ADOLESCENT COCAINE ABUSERS (1984) (15)
The sequential use of clonidine and naltrexone in the treatment of opiate addicts. (1984) (15)
Thyroid hormone potentiation of tricyclics. (1988) (15)
The Effect of Chronic Methamphetamine Exposure on the Hippocampal and Olfactory Bulb Neuroproteomes of Rats (2016) (15)
LSD and Ecstasy: Pharmacology, Phenomenology, and Treatment (1994) (15)
800-COCAINE: origin, significance, and findings. (1988) (15)
Effect of methadone dosage on clonidine detoxification efficacy. (1980) (15)
Random Urine Testing as an Intervention for Drug Addiction (2004) (14)
Endorphins in obesity and in the regulation of appetite and weight. (1984) (14)
Specificity of the TRH test for major depression in patients with serious cocaine abuse. (1985) (14)
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse. (2018) (14)
The therapeutic potential of exercise for neuropsychiatric diseases: A review (2020) (14)
Cannabis diagnosis of patients receiving treatment for cocaine dependence. (1990) (14)
Thyroid Stimulating Hormone and Growth Hormone Responses to Thyrotropin Releasing Hormone in Anorexia Nervosa (1981) (14)
The 800-COCAINE helpline: survey of 500 callers. (1984) (14)
Food Addiction: An Evolving Nonlinear Science (2014) (14)
URINARY EXCRETION OF NORADRENALINE METABOLITE DECREASED IN PANIC DISORDER (1983) (14)
Endorphins, Locus Coeruleus, Clonidine, and Lofexidine: (1982) (13)
Would induction of dopamine homeostasis via coupling genetic addiction risk score (GARS®) and pro-dopamine regulation benefit benzodiazepine use disorder (BUD)? (2018) (13)
A Novel Precision Approach to Overcome the “Addiction Pandemic” by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration (2021) (13)
Plasma Levels of Tricyclic Antidepressants in Panic Disorder (1984) (13)
Comorbidity and “Self-Medication” (2007) (13)
Connectivity Study of the Neuromechanism of Acute Acupuncture Needling during fMRI in “Overweight” Subjects (2015) (13)
Advances in psychopharmacology : predicting and improving treatment response (1984) (13)
Problem doctors: is there a system-level solution? (2006) (13)
The TRH test in affective disorders: experience in a private clinical setting. (1984) (13)
Traumatic brain injury and methamphetamine: A double-hit neurological insult (2020) (12)
Food and Addiction (2012) (12)
Biomarker Identification in Psychiatric Disorders: From Neuroscience to Clinical Practice (2015) (12)
Clinical correlates of the TRH infusion test in primary depression. (1982) (12)
A Review of Performance-Enhancing Drugs in Professional Sports and Their Spread to Amateur Athletics, Adolescents, and Other At-Risk Populations (2006) (12)
The thyrotropin-releasing hormone and dexamethasone suppression tests in the familial classification of depression (1983) (12)
Our evolved unique pleasure circuit makes humans different from apes: Reconsideration of data derived from animal studies (2018) (12)
Propranolol as adjunct to clonidine in opiate detoxification. (1987) (12)
Drug testing: medical, legal, and ethical issues. (1990) (12)
Ecstasy Toxicity (2006) (12)
Drug Testing and the DSM-IV (2000) (12)
The prevalence of marijuana (cannabis) use and dependence in cocaine dependence. (1990) (11)
THERAPEUTIC WINDOW FOR PLASMA HALOPERIDOL IN ACUTE SCHIZOPHRENIC PSYCHOSIS (1983) (11)
Addiction Treatment: Science and Policy for the Twenty-first Century (2008) (11)
Infectious diseases occurring in the context of substance use disorders: A concise review (2020) (11)
The TRH test and urinary MHPG in unipolar depression. (1983) (11)
The role of endorphins in opiate addiction, opiate withdrawal, and recovery. (1983) (11)
Implications of Food Addiction and Drug Use in Obesity (2011) (11)
Opiate Prescription Medication Dependence and Pain Perceptions (2007) (11)
Suicide risk associated with drug and alcohol addiction. (1992) (11)
LSD use among US high school students. (1994) (11)
Neurobiological vulnerability to low-dose amphetamine psychosis. (1978) (11)
Diagnostic and laboratory testing in psychiatry (1986) (11)
Addison's disease initially diagnosed as bereavement and conversion disorder. (1984) (11)
Pediatric Overeating and Obesity: An Epidemic (2003) (11)
Pilot clinical observations between food and drug seeking derived from fifty cases attending an eating disorder clinic (2016) (11)
Clonidine detoxification: a fourteen-day protocol for rapid opiate withdrawal. (1979) (11)
The Rapidly Changing Composition of the Global Street Drug Supply and its Effects on High-risk Groups for COVID-19 (2021) (10)
Upper-income cocaine abusers. (1984) (10)
Comparison of lumbar and thoracic epidural narcotics for postoperative analgesia in patients undergoing abdominal aortic aneurysm repair. (1997) (10)
Recent Developments in Alcoholism, vol. 9: Children of Alcoholics (1992) (10)
Behavioral and biochemical effects of FK 33-824, a parenterally and orally active enkephalin analogue (1979) (10)
Bromocriptine treatment of cocaine withdrawal symptoms. (1989) (10)
The Role of Alcohol, Drugs, and Deaths of Despair in the U.S.'s Falling Life Expectancy. (2020) (10)
Thyrotropin-releasing hormone test and male unipolar depression. (1981) (10)
Neuroendocrine abnormalities in affective disorders. (1982) (10)
Opiate and cocaine dependencies. Techniques to help counter the rising tide. (1985) (10)
Gambling and problem gambling prevalence among adolescents in Florida : a report to the Florida Council on Compulsive Gambling, Inc. (2002) (10)
Why are we consuming so much sugar despite knowing too much can harm us? (2015) (10)
Neurogenetics of acute and chronic opiate/opioid abstinence: treating symptoms and the cause. (2017) (10)
The Epidemiology, Attitudes, and Pharmacology of LSD Use in the 1990s (1994) (10)
Propranolol and stuttering. (1986) (9)
OUTPATIENT CLONIDINE DETOXIFICATION (1981) (9)
Cocaine and Alcoholism: Distinct or Part of a Spectrum (1988) (9)
Medical and Nonmedical Use of Prescription Opioids: Epidemiology and Prevalence (2006) (9)
Reward Deficiency Syndrome (RDS): A Cytoarchitectural Common Neurobiological Trait of All Addictions (2021) (9)
Central Stimulant Abuse (1986) (9)
Improving naltrexone compliance and outcomes with putative pro- dopamine regulator KB220, compared to treatment as usual (2020) (9)
Recent updates on drug abuse analyzed by neuroproteomics studies: Cocaine, Methamphetamine and MDMA (2014) (9)
The Treatment of Cocaine Addicts: Bromocriptine or Desipramine (1988) (9)
Multiple addictions: co-synchronous use of alcohol and drugs. (1990) (9)
Molecular Neurobiology of Addiction Recovery (2013) (9)
Naltrexone: A History and Future Directions (2018) (9)
Addiction research and treatment: the State of the Art in 2008 (2008) (9)
Promoting Self-Change from Addictive Behaviors: Practical Implications for Policy, Prevention, and Treatment (2008) (9)
Neuroanatomical sites of action of clonidine in opiate withdrawal: the locus coeruleus connection. (1981) (8)
Lofexidine blocks acute opiate withdrawal. (1982) (8)
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It “Blowin’ in the Wind”? (2022) (8)
Evoked Potentials and Memory/Cognition Tests Validate Brain Atrophy as Measured by 3T MRI (NeuroQuant) in Cognitively Impaired Patients (2015) (8)
Clinical utility of clonidine in opiate withdrawal. (1981) (8)
Smoking cessation and the risk for type 2 diabetes mellitus. (2010) (8)
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development. (2021) (8)
Depression and "Symptomless" Autoimmune Thyroiditis (1987) (8)
The Psychiatrist's Role in Integrating Pharmacological and Nonpharmacological Treatments for Addictive Disorders (1992) (8)
The adolescent cocaine epidemic. (1985) (8)
Hypothesizing Darkness Induced Alcohol Intake Linked to Dopaminergic Regulation of Brain Function. (2014) (8)
Marijuana Addictive Disorders: DSM-5 Substance-Related Disorders (2017) (8)
Urine drug testing is still an invaluable resource for primary care. (2010) (8)
PCP: a dangerous drug. (1988) (8)
Correction: Chronic Methamphetamine Effects on Brain Structure and Function in Rats (2017) (8)
Methods in tobacco abuse: proteomic changes following second-hand smoke exposure. (2012) (8)
Familial addiction in cocaine abusers. (1988) (8)
Organic Solvents and Aerosols: An Overview of Abuse and Dependence (1990) (7)
Performance Enhancing, Non-Prescription Use of Erectile Dysfunction Medications (2006) (7)
Treatment outcome in cocaine abusers. (1986) (7)
The American Opioid Epidemic: From Patient Care to Public Health. (2021) (7)
Methamphetamine-Induced Psychosis: Who Says All Drug Use Is Reversible? Treatment Needs to Take into Account Persistent Cognitive Impairment and Comorbid Disorders (2017) (7)
Fungal infection associated with intravenous drug abuse: a case of localized cerebral phycomycosis. (1988) (7)
Cannabis-Induced Hypodopaminergic Anhedonia and Cognitive Decline in Humans: Embracing Putative Induction of Dopamine Homeostasis (2021) (7)
Food addiction? (2009) (7)
The effect of epidural/general and cervical plexus block anesthesia on activated clotting time in patients undergoing vascular surgery. (1993) (7)
Global Evidence for the Key Role of the Dopamine D2 Receptor Gene (DRD2) and DRD2 Receptors in Alcoholism (2017) (6)
Methods in systems biology of experimental methamphetamine drug abuse. (2010) (6)
Sensitivity to alcohol in obese patients: a possible role for food addiction. (2011) (6)
Central stimulant abuse: neurochemistry and pharmacotherapy. (1986) (6)
A Marked Increase in Cocaine-Related Deaths in the State of Florida (2007) (6)
Benzodiazepines: The Dissociation of Addiction From Pharmacological Dependence/Withdrawal (1995) (6)
The Prevalence of Alcohol Dependence in Cocaine Dependence in an Inpatient Population (1989) (6)
Benzodiazepines: reconsidered. (1990) (6)
The Medical Management of Nicotine Dependence in the Workplace (1989) (6)
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward (2015) (6)
Dopaminergic Neurogenetics of Sleep Disorders in Reward Deficiency Syndrome (RDS). (2014) (6)
Varenicline, appetite, and weight reduction. (2008) (6)
Cocaine Abuse: New Directions in Treatment and Research (1989) (6)
Psychopharmacologic treatment of depression. (1984) (6)
Hepatitis in 101 Consecutive Suburban Cocaine and Opiate Users (1987) (6)
The New User of Cocaine: Evidence from 800-COCAINE (1988) (6)
Nortriptyline Plasma Levels and Clinical Response in Patients with Familial Pure Unipolar Depression and Blunted TRH Tests (1984) (5)
Comprehensive Thyroid Evaluation in Psychiatric Patients (1984) (5)
Cortisol Secretion and Urinary MHPG in Unipolar Depression (1984) (5)
Exposure to Narcotics in the Operating Room Poses Occupational Hazard for Anesthesiologists (2004) (5)
The Good News About Depression: Cures And Treatments In The New Age Of Psychiatry (1986) (5)
The pharmacologic treatment of alcohol and cocaine abuse. Integration of recent findings into clinical practice. (1992) (5)
Second-Hand and Third-Hand Drug Exposures in the Operating Room: A Factor in Anesthesiologists’ Dependency on Fentanyl (2010) (5)
Prevalence and Pattern of Use (1991) (5)
Process addictions in 2012: food, internet and gambling (2012) (5)
Hypothesizing in the Face of the Opioid Crisis Coupling Genetic Addiction Risk Severity (GARS) Testing with Electrotherapeutic Nonopioid Modalities Such as H-Wave Could Attenuate Both Pain and Hedonic Addictive Behaviors (2022) (5)
Retraction: Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics (2015) (5)
The Dexamethasone Suppression and Thyrotropin-Releasing Hormone Tests and Response to Treatment in Unipolar Depression (1983) (5)
Editorial [Hot topic:Food Addiction & Obesity Treatment Development (Executive Guest Editors: Mark S. Gold and Noni A. Graham)] (2011) (5)
Perioperative fluid management. (1992) (5)
Addictive disorders in medical populations (2014) (5)
Neurogenetics and Neurobiology of Dopamine in Anhedonia (2014) (5)
Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics (2015) (5)
Prescription opioids and overdose deaths. (2009) (5)
Laboratory Diagnosis of Cocaine (1986) (5)
Speed, cocaine, and other psychostimulants death rates. (2007) (4)
The American Opioid Epidemic: From Patient Care to Public Health. (2021) (4)
Eating disorders, overeating and pathological attatchment to food: Independent or addictive disorders? (2004) (4)
Health Care Economics for Integrated Addiction Treatment in Clinical Settings (1998) (4)
Serum prolactin and opiate withdrawal (1980) (4)
Sedative-hypnotics: pharmacology and use. (1989) (4)
Effect of multiple time point sampling on the sensitivity of the dexamethasone suppression test. (1983) (4)
Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling. (2021) (4)
Prevention and Education (1995) (4)
Number of cortisol time-points and dexamethasone suppression test sensitivity for major depression (1985) (4)
Clonidine and lofexidine: Evidence for an endorphin–norepinephrine connection mediating opiate withdrawal. (1983) (4)
Diagnosis and treatment of adolescent substance abuse. (1985) (4)
Physicians' experiences with impaired colleagues. (2010) (4)
Pharmacological therapies for drug & alcohol addictions (1995) (4)
Some possible neurological substrates in Attention Deficit Disorders. (1983) (4)
Regarding “Is Cigarette Smoking a Gateway to Alcohol and Illicit Drug Use Disorders? A Study of Youths with and without Attention Deficit Hyperactivity Disorder” (2006) (4)
Should We Embrace Vaccines for Treating Substance- Related Disorder, A Subset of Reward Deficiency Syndrome (RDS)? (2015) (4)
Methods in drug abuse neuroproteomics: methamphetamine psychoproteome. (2009) (4)
Interpretation of drug abuse testing: strengths and limitations of current methodology. (1985) (4)
Psychopharmacology of MDMA (Ecstasy) (2001) (4)
After the Storm: Healing After Trauma, Tragedy and Terror (2007) (4)
Decrease in serum prolactin by naloxone: evidence against antidopamine and antipsychotic effects. (1979) (4)
Historical and Conceptual Issues (2005) (4)
Medication-assisted therapies for opioid use disorders in patients with chronic pain (2020) (4)
Hypothesizing Nutrigenomic-Based Precision Anti-Obesity Treatment and Prophylaxis: Should We Be Targeting Sarcopenia Induced Brain Dysfunction? (2021) (4)
Proposing a “Brain Health Checkup (BHC)” as a Global Potential “Standard of Care” to Overcome Reward Dysregulation in Primary Care Medicine: Coupling Genetic Risk Testing and Induction of “Dopamine Homeostasis” (2022) (4)
Women tipping the scale during pregnancy: a special population for obesity interventions, treatments and clinical trials. (2011) (3)
Organic solvent and aerosol abuse. (1991) (3)
The Comprehensive Evaluation of Cocaine and Opiate Abusers (1985) (3)
Elevation of Pro-inflammatory and Anti-inflammatory Cytokines in Rat Serum after Acute Methamphetamine Treatment and Traumatic Brain Injury (2021) (3)
Symptoms of ADHD or marijuana use? (2007) (3)
Nicotine-Dependent Psychiatric Patients (1991) (3)
TRH Test Identification of Thyroid-Responsive Depression (1989) (3)
Performance Enhancing Medications and Drugs of Abuse (2007) (3)
Dr. Dackis and Associates Reply (1986) (3)
Neurogenetic and Epigenetic Aspects of Cannabinoids (2022) (3)
Urinary basal body temperature in anorexia nervosa (1989) (3)
Psychoactive Drugs Like Cannabis -Induce Hypodopaminergic Anhedonia and Neuropsychological Dysfunction in Humans: Putative Induction of Dopamine Homeostasis via Coupling of Genetic Addiction Risk Severity (GARS) testing and Precision Pro-dopamine Regulation (KB220). (2021) (3)
The neurobiological implication of clonidine HCl. (1981) (3)
Response to "Comorbid psychiatric diagnoses and their association with cocaine-induced psychosis in cocaine-dependent subjects". (2008) (3)
Scopolamine as Treatment for Nicotine Polacrilex Dependence (1989) (3)
Neurobiology of addiction and recovery: the brain, the drive for the drug, and the 12-step fellowship. (1994) (3)
Accuracy of Dexamethasone Suppression Test in Alcoholics (1983) (3)
Comparison of Bromocriptine and Desipramine in Cocaine Withdrawal (1989) (3)
Chapter 31 – Chemical Dependency: Opioids (2007) (3)
The 24-Hour LH Test in the Diagnosis and Assessment of Response to Treatment of Patients with Anorexia Nervosa (1982) (3)
Opioid, Cocaine and Methamphetamine Overdose Crisis and Deaths in 2021 (2021) (3)
Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects (2022) (3)
Clinical utility of clonidine in opiate withdrawal: a study of 100 patients. (1981) (3)
Identification and treatment of benzodiazepine abuse. (1989) (3)
Methadone-induced endorphin dysfunction in addicts. (1982) (3)
Dual diagnoses: psychiatric syndromes in alcoholism and drug addiction. (1991) (3)
Socioeconomic inequities often translate into health inequalities. (2006) (3)
Investigating the effects of low dose alcohol on neural timing using functional MRI (2011) (3)
Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms? (2022) (3)
Anabolic steroid abuse (2006) (3)
Clonidine in opiate withdrawal. (1978) (3)
Randomized fMRI Trial of the Central Effects of Acute Acupuncture on Glucose Levels and Core Body Temperature in “Overweight” Males (2011) (3)
New Directions in the Pharmacological Treatment of Food Addiction, Overeating, and Obesity (2014) (3)
Potential Role of Addiction Pharmacotherapy in Problematic Eating Behavior (2014) (3)
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry? (2022) (3)
The contemporary alcoholic. (1990) (3)
Treatment of Alcohol and Drug Dependence in 2011 and Relevance to Food Addiction (2012) (2)
Dopaminylation in Psychostimulant Use Disorder Protects Against Psychostimulant Seeking Behavior by Normalizing Nucleus Accumbens (NAc) Dopamine Expression. (2021) (2)
Researching Mitigation of Alcohol Binge Drinking in Polydrug Abuse: KCNK13 and RASGRF2 Gene(s) Risk Polymorphisms Coupled with Genetic Addiction Risk Severity (GARS) Guiding Precision Pro-Dopamine Regulation (2022) (2)
The TRH Test in the Diagnosis of Affective Disorders and Schizophrenia (1984) (2)
Dexmedetomidine as Primary Sedative in CEA Patients: In Reply (2004) (2)
Looking beyond the opioid receptor: A desperate need for new treatments for opioid use disorder (2022) (2)
Benzodiazepines: a major problem. Introduction. (1991) (2)
Raising Endogenous Brain Levels of Kynurenic Acid May Produce Anti-Reward and Enhance Suicide Ideation (2014) (2)
Depression: diagnosis and treatment with tricyclic antidepressants. (1981) (2)
Double Trouble: Depression and Alcohol Abuse in the Adolescent Patient (2005) (2)
The Role of the Psychiatrist in Treatment of Relapse in Addictive Disorders (1995) (2)
Exercise for the overweight and obese. (2011) (2)
Calvin klein (CK) designer cocktail, new “Speedball” is the “grimm reaper”: Brain dopaminergic surge a potential death sentence (2020) (2)
Legal Implications: Regulating Sales and Marketing (2012) (2)
Biomedical Psychiatric Therapeutics (1986) (2)
Evidence From Complete Thyroid Function Evaluation (2017) (2)
Smoking and Illicit Drug Use. (1998) (2)
The Fair Oaks Hospital cocaine treatment program. (1984) (2)
The future of private psychiatric hospitals. (1982) (2)
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse? (2019) (2)
Varenicline and adult ADHD. (2008) (2)
Pharmacological Drug Effects on Brain and Behavior (2010) (2)
Benzodiazepines: A Major Problem (1991) (2)
Neurological Effects of Alcohol (1991) (2)
Coupling Neurogenetics ( GARS TM ) and a Nutrigenomic Based Dopaminergic Agonist to Treat Reward Deficiency Syndrome ( RDS ) : Targeting Polymorphic Reward Genes for Carbohydrate Addiction Algorithms Journal of Reward Deficiency Syndrome (2016) (2)
Dual Diagnosis (2005) (2)
Making Sense of the Future (2009) (2)
Psychological and Psychiatric Consequences of Opiates (1998) (2)
Pregnancy and substance use. (2013) (2)
Relationships between Drugs of Abuse and Eating (2012) (2)
An individualized 24-hour therapeutic approach to a psychotic child (1972) (2)
Physicians and drug screening. (2006) (2)
Smoking and cardiovascular risk in diabetes mellitus (2010) (2)
Second- and third-hand opium smoke exposure in the women and children of Afghanistan (2011) (2)
The night/day imagery paradox of selected psychotic children. (1975) (2)
The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in alcoholics. (1983) (2)
Neuroquantum Theories of Psychiatric Genetics: Can Physical Forces Induce Epigenetic Influence on Future Genomes? (2015) (2)
Precision Behavioral Management (PBM) and Cognitive Control as a Potential Therapeutic and Prophylactic Modality for Reward Deficiency Syndrome (RDS): Is There Enough Evidence? (2022) (2)
More on self-medication and drug abuse. (1986) (2)
Buprenorphine and Naloxone Combinations and Dopamine (2018) (2)
Re: "estimates of nondisclosure of cigarette smoking among pregnant and nonpregnant women of reproductive age in the United States". (2011) (2)
New Treatments for Opiate and Cocaine Users: But What About Marijuana? (1986) (2)
Brief educational intervention to improve medical student competence in managing patients exposed to secondhand smoke. (2014) (2)
from the guest editor: Obesity and Eating Disorders (2003) (2)
Obesity and Substance Use Disorders (2006) (2)
Addiction Research and Treatment (2008) (2)
The Physician's Role in Recognition and Treatment of Alcohol Dependence and Comorbid Conditions (2005) (2)
Treating Addiction as a Human Process (2000) (2)
Caffeine in miscarriages: it's not just in the coffee. (2008) (2)
Pharmacological Therapeutics for Detoxification in Addictive Disorders (2010) (1)
Psychedelic drugs for psychiatric disorders (2022) (1)
NALOXONE AND NALTREXONE: Endorphin Antihormones (1982) (1)
EFFECT OF EPIDURAL/GENERAL VS GENERAL ANESTHESIA ON CATECHOLAMINE LEVELS AND HEMODYNAMICS DURING ABDOMINAL AORTIC CROSS-CLAMPING (1992) (1)
Marked increases in USA marijuana and LSD: Results of annual junior and senior high school survey (1994) (1)
Update on the Ecstasy Epidemic (2000) (1)
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids (2022) (1)
Handbook of Clinical Alcoholism Treatment (2005) (1)
Effect of Second-Hand Tobacco Smoke on the Nitration of Brain Proteins: A Systems Biology and Bioinformatics Approach. (2017) (1)
“Antianxiety and opiates” (1982) (1)
Bariatric surgery: Potential post-operative heightened sensitivity to substances or behaviors (2021) (1)
Bromocriptine (2022) (1)
What's new in laboratory testing procedures for psychiatrists? (1984) (1)
Models for care and research: closed-staff private hospitals. (1983) (1)
Cocaine: killer on the streets. (1984) (1)
Identifying depression secondary to lithium-induced hypothyroidism. (1984) (1)
Cocaine abuse: techniques of assessment, diagnosis, and treatment. (1985) (1)
Laboratory Diagnosis of Alcoholism and Drug Addiction (1991) (1)
Introduction (2007) (1)
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) via Activation of Neuro-immunological Function in the Face of a Viral Pandemic. (2021) (1)
Opioid treatment for chronic back pain and its association with addiction. (2007) (1)
Medicinal Marijuana, Stress, Anxiety, and Depression: Primum non nocere. (2020) (1)
Increased assessment and monitoring needed for patients receiving methadone. (2008) (1)
Addictive Disorders in Medical Populations: Miller/Addictive Disorders in Medical Populations (2010) (1)
Cocaine, marijuana, alcohol, and violence: Results of annual high school survey (1995) (1)
Endorphin Dysfunction in Panic Anxiety and Primary Affective Illness (1982) (1)
Teens + Marijuana: (Still) a Dangerous Mix (2008) (1)
Perspectives on the Opioid Crisis (2015) (1)
Successful Treatment of Physicians With Addictions (2009) (1)
Dual disorders: nosology, diagnosis, & treatment confusion--chicken or egg? Introduction. (2007) (1)
Psychiatric Problems Associated with Marijuana Use (1989) (1)
Substance Abuse and Psychiatric Dual Disorders (2005) (1)
Master African-American artists should be featured on JNMA covers. (2006) (1)
Response by Mark Gold et al. (2006) (1)
Advances in Psychopharmacology: Improving Treatment Response (2017) (1)
Close to Home: Moyers on Addiction (1998) (1)
Prescription Opioids and Addiction (2015) (1)
Drug-Induced Compulsive Behaviors: Exceptions to the Rule (2009) (1)
Thoracic Versus Lumbar Administration of Epidural Opioids for Postoperative Analgesia in Patients Undergoing Abdominal Aortic Aneurysm Repair (1994) (1)
The Encyclopedia of Alcoholism and Alcohol Abuse (2010) (1)
Understanding that Addiction Is a Brain Disorder Offers Help and Hope (2022) (1)
Clinical Laboratory Testing in Drug Abuse and Addiction (1989) (1)
Why haven't we solved the addiction crisis? (2022) (1)
Treatment of Marijuana Abuse (1989) (1)
Cocaine Abuse: Neurochemistry, Phenomenology, and Treatment: (496912006-007) (1985) (1)
Medical Complications of Alcoholism (1991) (1)
Varenicline and Adult ADHD (2008) (1)
Addiction Psychiatry: Current Diagnosis and Treatment (1996) (1)
Dopamine and serum prolactin in methadone withdrawal. (1981) (1)
Hypothesizing Major Depression as a Subset of Reward Deficiency Syndrome (RDS) Linked to Polymorphic Reward Genes: Considerations for Translational Medicine Approaches for Future Drug Development (2019) (1)
Chronic medical complications of drug abuse. (1985) (1)
Correction: Hypersexuality Addiction and Withdrawal: Phenomenology, Neurogenetics and Epigenetics (2015) (1)
Opioid and dopamine genes interact to predict precision naltrexone response in alcohol use disorder: Interpretation misfires (2021) (1)
Qualitative vs. Quantitative Methods in Psychiatric Research: Updated. (2019) (1)
Is There a Treatment or Treatments for Drug Abuse or Addiction (1993) (1)
The Effects of Alcohol Use During Medical School (2005) (1)
Variety and hyperpalatability: are they promoting addictive (2011) (1)
Reward Deficiency Solution System (RDS): A Tale of Three Scientists (2014) (1)
Rapid Anti-Depressant Relief by Ketamine: Exploring A Complex Mechanism of Action (2019) (1)
THE TRH TEST IN DEPRESSIVE AND MANIC-DEPRESSIVE ILLNESS (1982) (1)
Introduction and History (1991) (1)
Patients With Substance Abuse Problems: Effective Identification, Diagnosis, and Treatment (2007) (1)
A Humanistic Approach to the Study of Memory. (2006) (0)
Food addiction & obesity treatment development. (2011) (0)
Hedonic Deficit in Chronic Schizophrenia (1979) (0)
Tobacco in the 1990s (1995) (0)
Educational intervention to improve secondhand smoke awareness, competency, and screening among health professions students (2012) (0)
The effect of nucleus accumbens lesions on appetite, sexual function, and nicotine dependence in recovering heroin addicts (2013) (0)
Correction to: Elevation of Pro‑inflammatory and Anti‑inflammatory Cytokines in Rat Serum after Acute Methamphetamine Treatment and Traumatic Brain Injury (2021) (0)
Addictive Disorders in Nutritional Diseases ‐ From an Addictions Viewpoint (2010) (0)
Depression-related improvement with vardenafil for erectile response. (2006) (0)
Beyond the Killing Fields (2019) (0)
Methodological considerations of label-free neuroproteomics: A case study involving a rat model of chronic methamphetamine exposure (2015) (0)
Genetic Addiction Risk Score (GARS): Molecular Neurogenetic Evidence for Predisposition to Reward Deficiency Syndrome (RDS) (2014) (0)
Opioid Peptides in Substance Abuse (1995) (0)
Polygenic and multi locus heritability of alcoholism: Novel therapeutic targets to overcome psychological deficits (2020) (0)
441. Hallucinogen and other illicit drug uses increases in the USA (1996) (0)
TBI autoantibodies colocalized with GFAP in primary rat astrocytes. (2014) (0)
Tipsheet: Physician Substance Abuse in the Workplace (2014) (0)
Dopaminergic and other genes related to reward induced overeating, Bulimia, Anorexia Nervosa, and Binge eating (2021) (0)
Transmodulation of Dopaminergic Signaling to Mitigate Hypodopminergia and Pharmaceutical Opioid-induced Hyperalgesia (2020) (0)
Eating Disorders and Substance Abuse (1993) (0)
Depression vs. Craving In Alcoholic Relapse (1994) (0)
Cocaine in the 1990s (1993) (0)
Psychopharmacology in Student Health (College and Graduate): Substance Use Disorders and Psychiatry (2020) (0)
Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing (2022) (0)
Reward Deficiency Syndrome Model of Addiction Psychiatry: Everywhere, Everything, and All at Once (2022) (0)
Comprar Addictive Disorders In Medical Populations | Norman S Miller | 9780470740330 | Wiley (2010) (0)
Translating Neurobiology into Practice in Tobacco, Alcohol, Drug, and Behavioral Addictions (2019) (0)
Examining substance abuse and relapse among impaired physicians (2018) (0)
Correction to: Qualitative vs. Quantitative Methods in Psychiatric Research: Updated. (2019) (0)
Laboratory Detection of Marijuana Use (1989) (0)
CLONIDINE FOR OPIATE WITHDRAWAL (1981) (0)
In Reply I-Root Causes of the Opioid Crisis. (2018) (0)
Reward Deficiency Syndrome (RDS): Is there a Solution? (2014) (0)
Multidisciplinary theories of addiction. (2011) (0)
Nicotine addiction. (1996) (0)
Treatment and the Role of the Physician (1995) (0)
Chemical Dependency: Nonopioids (2007) (0)
99. Measuring Mindfulness and Examining Its Relationship with Alcohol Use and Negative Consequences. ............ Page 70 (0)
The Clinical Manifestions of Cocaine Abuse (1993) (0)
The thalamus, circa 2007. (2007) (0)
Introduction (2006) (0)
Teens and Marijuana (2008) (0)
Understanding addiction from biology to behavior. (2010) (0)
The ongoing quest to unlock the secrets of the human brain—Where do we stand? (2009) (0)
Clinical Diagnosis of Alcoholism (1991) (0)
The American Psychiatric Publishing Textbook of Sub- stance Abuse Treatment, 3rd ed., edited by Marc Galan- (2005) (0)
What's New in the Treatment of Overeating and Obesity? (2012) (0)
Middle-age initiation of alcohol consumption unlikely to cause addiction. (2008) (0)
Comparison of Hetastarch to Albumin for Perioperative Bleeding in Patients Undergoing Abdominal Aortic Aneurysm Surgery: A Prospective, Randomized Study (1991) (0)
World nutrition. The year of 2012. What next (2013) (0)
Alcohol and Drug Abuse and Dependence in Geriatric Populations (1991) (0)
Assault and battery (1983) (0)
Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index (2022) (0)
Drug-induced compulsive behaviors: exceptions to the rule. (2009) (0)
Reward Deficiency Syndrome Solution System (RDSSS) A Genetically Driven Putative Inducer of "Dopamine Homeostasis" as a Futuristic Alternative to Enhance Rehabilitation Instead of Incarceration. (2023) (0)
The Association Between Binge Eating, Obesity, and Addiction (2020) (0)
A global perspective on psychopharmacology from bench to bedside. (2008) (0)
Cocaine Update: From Bench to Bedside (2022) (0)
TCA and in vivo methylation. (1985) (0)
Ethno-psychopharmacology in an ethnocentric society. (2009) (0)
Benzodiazepine Use and Addiction among Alcoholics (1991) (0)
Introduction (2004) (0)
Psychopathology, Genes, and Neuroscience: What Does the Future Hold? (2006) (0)
Psychological and Psychiatrie Consequences of Opiates (1998) (0)
Endorphins and Mental Disease (1985) (0)
Drugs and Narcotics in History (1996) (0)
Regional anesthesia in carotid surgery: technique and results (1998) (0)
A marriage of psychology and economics: New approaches to the study of disordered gambling and addiction. (2008) (0)
Basic Science of Addiction Medicine. (2006) (0)
442. Tobacco and marijuana use increases in junior and senior high school students (1996) (0)
The Psychiatric Aspects of Tobacco Use (1995) (0)
Medical and Psychiatric Complications of Cocaine Abuse With Possible Points of Pharmacological Treatment (2022) (0)
Treatment outcome in cocaine abusers.: (469912004-001) (1986) (0)
A 40-year-old Anesthesiologist who collapses in the operating room (2005) (0)
A Model Cessation Program (1995) (0)
A 21ST CENTURY PERSPECTIVE ON DEPRESSION, REWARD GENES, AND DNA POLYMORPHIC TARGETED NUTRIGENOMIC RESOLUTION (2017) (0)
Fatty Acid-Binding Protein 5 Gene Deletion Enhances Nicotine-Conditioned Place Preference: Illuminating the Putative Gateway Mechanisms (2023) (0)
Neuroendocrine diagnostic test in psychiatry. (1981) (0)
“Preaddiction” construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation (2022) (0)
Barriers to Herpes Zoster Vaccination (2010) (0)
TRH Stimulation Test in Psychiatry (1989) (0)
Prescription Opioids and Overdose Deaths. Authors' reply (2009) (0)
Addiction à l’alimentation (2018) (0)
Alzheimer's amyloidosis induces global changes in protein homeostasis in the brains of transgenic mice (2011) (0)
List of Contributors (2019) (0)
Tobacco and the Body (1995) (0)
Impaired Physicians (2020) (0)
Use of dopamine agonists for the preparation of medicaments for the treatment of addiction to psychoactive drugs (1986) (0)
Meet Our Co-Editor (2022) (0)
The Contribution of Blood Levels to the Reversibility of “Resistant” Depression (1985) (0)
Diagnosis of Marijuana Dependency (1989) (0)
Pathological gambling focused CBT: The application of addiction-based treatments provides another tool in the therapist's toolbox. (2007) (0)
Functional MRI detection of brain changes related to effectiveness of bariatric surgery as treatment for obesity (2005) (0)
The Neurobiological Effects of Tobacco (1995) (0)
The treatment of therapists who sexually offend. (2021) (0)
ホルモンおよび神経による食物報酬、摂食行動、および肥満の制御機構 (2014) (0)
Alcoholism and Clinical Psychiatry (1983) (0)
When Food Is an Addiction (2019) (0)
Effects of Cathinones (Bath Salts) on Cultured Primary Neurons/Astroglia Cells and Neurobehavioral Functions in Mice (2022) (0)
Inpatient Treatment and Relapse Prevention (1993) (0)
Drugs and Violence in the USA (2008) (0)
Human severe TBI patients developed circulating IgG autoantibodies against brain proteins within the 50-38 kDa range after injury. (2014) (0)
Smoking and Special Populations (1995) (0)
Chapter 79 – Food Addictions (2013) (0)
The diagnosis and treatment of alcohol dependence. (1987) (0)
ON CALL Neurology (1998) (0)
Etiology and Prevention of Stimulants (Including Cocaine, Amphetamines and Misuse of Prescription Stimulants) (2013) (0)
Calpain-associated GFAP breakdown to 38 kDa occurred in vivo . (2014) (0)
Other Drug Use among Alcoholics (1991) (0)
Food-specific addictions: brain mechanisms and pharmacological treatment approaches (2013) (0)
A new frontier for executive functions. (2013) (0)
Epigenetic Changes in Addiction and Eating Disorders (2012) (0)
Advances in Psychopharmacology (1984) (0)
Molecular Neurobiology of Recovery with the Twelve Steps (2013) (0)
Physician drug addictions: Additional data support the gold hypothesis (2007) (0)
Comparison of the dexamethasone suppression test and the cortisol suppression index. (1984) (0)
Endocrinological Diseases Mimicking Affective Disorders (1989) (0)
Outpatient and Inpatient Treatment of Alcoholism (1991) (0)
Posthospital outcome in suburban drug addicts. (1985) (0)
This Issue: Alcohol Abuse (2005) (0)
Pharmacological Therapeutics for Relapse Reduction in Addictive Disorders (2010) (0)
Also in the mind (2012) (0)
A new marijuana use epidemic: Marked marijuana use increases in annual (1994) survey (1995) (0)
Prevention of Marijuana Abuse (1989) (0)
Treatment of Alcoholism: General Considerations (1991) (0)
Varenicline and Adult ADHD. Authors' reply, Commentary (2008) (0)
The History of Cocaine (1993) (0)
Treatment of the Dual-Diagnosed Alcoholic Patient (1991) (0)
Depression and Abnormal Endocrinologic Tests-Reply (1981) (0)
Addiction Research Update 2009 (2009) (0)
Performance Enhancement and Adverse Consequences of MDMA (2006) (0)
Fair Oaks Clinical Research Center. (1989) (0)
514. Identifying alcohol abuse: MDs and the cage (2000) (0)
The Safety of Dex As A Primary Sedative For Awake Carotid Endarterectomy (2005) (0)
Living Without Cruelty (1990) (0)
The Role of Drug Testing (1993) (0)
Neuroprotection: Promise and Pitfalls. (2006) (0)
Psychosocial Assessment and Treatment of Bariatric Patients (2013) (0)
Addictive Disorders as an Integral Part of the Practice of Medicine (2010) (0)
Medical Problems Associated with Marijuana Use (1989) (0)
Drugs and Violence in the United States (2008) (0)
Marijuana Use and Abuse (1989) (0)
Right, wrong (2006) (0)
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia’s Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family (2022) (0)
Suicide in Alcoholism and Drug Addiction (1991) (0)
Suggestions for the DSM-IV criteria for substance use disorders. (1989) (0)
The DRD2 Taq1A A1 Allele May Magnify the Risk of Alzheimer’s in Aging African-Americans (2017) (0)
Diagnosis of Psychiatric Syndromes in Alcoholism and Drug Addiction (1991) (0)
Initiating abstinence: Rewarding patients' early efforts at sobriety. (2008) (0)
Depression and Hypothyroidism-Reply (1983) (0)
Setting the Standard for Recovery: Physicians' Health Programs (2009) (0)
Laboratory diagnosis of cocaine: intoxication and withdrawal. (1986) (0)
Neuroendocrine Responses in Diagnostic Groups-Reply (1982) (0)
Physicians, the Elderly, Adolescents, and Substance Abuse (1993) (0)
Effects of oxygen in an invertebrate model of amphetamine neurotoxicity (2011) (0)

This paper list is powered by the following services:

Other Resources About Mark S. Gold

en.wikipedia.org

What Schools Are Affiliated With Mark S. Gold?

Mark S. Gold is affiliated with the following schools:

Mark S. Gold's Academic­Influence.com Rankings

Mark S. Gold's Degrees

Why Is Mark S. Gold Influential?

Mark S. Gold's Published Works

Published Works

Other Resources About Mark S. Gold

What Schools Are Affiliated With Mark S. Gold?

Mark S. Gold's AcademicInfluence.com Rankings